Phibro Animal Health Corporation
PAHC
$38.26-0.10%
Delayed · as of Oct 12, 2026, 11:45 AM ET
Mkt cap
$1.25B
EV/Sales
0.78
P/E ratio
N/A
FY2026 Revenue
$1.52B
EPS (9mo ended 2026-03-31)
$1.90
Gross Margin (FY2026)
33.76%
Profit Margin (FY2026)
6.57%
Beta
N/A
Div yield
1.51%
Sector
Healthcare
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported PAHC revenue for 2026-06-30 was $1.52B. Net income was $99.7M. Revenue was up 17.1% from 2025-06-30 to 2026-06-30. PAHC currently screens at market cap $1.25B.
Use this PAHC research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PAHC income, balance, and cash tables.
Phibro Animal Health Corporation (PAHC) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Phibro Animal Health Corporation (PAHC) revenue for Jun 30, 2026 was $1.52B. Net income was $99.7M. Statements: https://lician.com/financials/pahc
Phibro Animal Health Corporation (PAHC) market capitalization is $1.25B on the latest cached snapshot.
Phibro Animal Health Corporation (PAHC) cached previous close $38.30; day range $38.26 – $38.28; volume 30,858. Session quote: https://lician.com/quote/pahc
Phibro Animal Health Corporation (PAHC) latest cached earnings event is "PAHC earnings" on Aug 26, 2026. Earnings calendar: https://lician.com/earnings
The latest cached PAHC filing is 8-K · Aug 26, 2026. Filings: https://lician.com/sec/pahc